It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.

cellprime

32 Results Advanced Search

Site Content (8)

Can't Find What You're Looking For?

Contact Customer Service

Lysozymes | Biopharmaceutical Manufacturing | Merck
Our CellPrime® recombinant human lysozyme is designed specially for use in biopharmaceutical production processes, diagnostic applications and life science research.
Press Release: Merck Introduces CellPrime™ Recombinant Human Lysozyme for Increased Protein Recovery From E. coli Production Systems
Merck, today announced the launch of CellPrime™ recombinant human lysozyme for increased recovery efficiencies in biopharmaceutical production.
Non-animal Origin Supplements | Biopharmaceutical Manufacturing | Merck
Merck offers a variety of non-animal origin supplements, specifically formulated for cell culture applications.
Press Release: Merck Announces Exclusive Supply and Marketing Agreement With Ventria Bioscience to Expand its CellPrime™ Line of Non-animal Origin Products
Merck, today announced an exclusive collaboration with Ventria Bioscience through which Ventria will manufacture and supply a recombinant product that meets the requirements for use as a raw material in cGMP biopharmaceutical production.
Cell Culture Ingredients and Supplements | Biopharmaceutical Manufacturing | Merck
Our portfolio of cell culture ingredients and supplements can help you stabilize your processes and obtain optimal yields with consistent results.
Cleavage, Lysis and Purification after Harvest | Biopharmaceutical Manufacturing | Merck
Our products for the processing steps that follow cell harvest include Benzonase® endonuclease for DNA removal and lysozomes for cell lysis.
Press Release: Merck Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement
Merck, today announced an exclusive agreement to sell recombinant human insulin manufactured by the United Arab Emirates-based pharmaceutical production company Julphar Diabetes.
Viral Safety Assurance | Prevent | Merck
Cell lines used for the production of biotherapeutics need to be extensively characterized before use to determine the levels of endogenous retrovirus-like particles, and whether unexpected adventitious virus is present in the source cells.